Product Images Duloxetine

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 13 images provide visual information about the product associated with Duloxetine NDC 50268-269 by Avpak, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

50 - 269 15

50 - 269 15

This is a description of Duloxetine Delayed-release Capsules, USP that come in 50 capsules (5x10) unit dose with a prescription (Rx) only. Pharmacists are meant to dispense the medication guide provided separately to each patient. Each capsule contains 22.4 mg of duloxetine hydrochloride USP which is equal to 20 mg of duloxetine. The dosage will vary depending on the user, and it is instructed not to be chewed or crushed. It is important to keep the product out of reach of children and store it at a temperature between 20° to 25°C (66° to 77°F). The text also references a specific location AR, Pkl TN 38478, and provides a few dates ending in F) but no further context is given.*

30 - 270 13

30 - 270 13

NOC 50268.270-13 Duloxetine Delayed-release Capsules, USP. This is a medication description.*

30 - 271 13

30 - 271 13

The text contains some drug information including the drug name "Duloxetine", and it appears to be in the form of delayed-release capsules. The text also shows a "NOC" number, which may be a product identifier. However, the other characters seem to be random and do not provide any useful information.*

duloxetinestructure - duloxetinestructure

duloxetinestructure - duloxetinestructure

figure1 - figure1

figure1 - figure1

figure10 - figure10

figure10 - figure10

figure2 - figure2

figure2 - figure2

figure3 - figure3

figure3 - figure3

This appears to be a graph or chart showing the percentage of patients improved based on different treatments for pain. The treatments listed are Duloxetine 60mg BID, Duloxetine 60mg OD, Duloxetine 20mg OD, and Placebo. The x-axis represents the percent improvement in pain from baseline, and the y-axis represents the number of patients. The graph appears to be showing that Duloxetine 60mg BID and Duloxetine 60mg OD had the highest percentage of patients improved, while the placebo had the lowest.*

figure4 - figure4

figure4 - figure4

figure5 - figure5

figure5 - figure5

figure6 - figure6

figure6 - figure6

figure8 - figure8

figure8 - figure8

This appears to be a graph or chart showing the percentage of patients who have improved, and the percent improvement in pain from baseline (BOCF). Without more context or a clearer image, it is difficult to provide more specific information.*

figure9 - figure9

figure9 - figure9

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.